Skip to main content

Provider

By Adam Ang | 10:11 pm | February 16, 2022
The company has entered into a collaboration to develop a care monitoring platform.
HIMSS22
By Emily Olsen | 03:01 pm | February 16, 2022
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
By Emily Olsen | 01:08 pm | February 15, 2022
During the first six months of the pandemic, 13% of outpatient visits were conducted through telehealth. By March to August 2021, that number slipped to 8%.
By Adam Ang | 12:20 am | February 15, 2022
MFine users can now book tests from Datar Cancer Genetics.
By Adam Ang | 12:17 am | February 15, 2022
The telehealth service is expanding across Asia two years since its launch in Singapore.
By Emily Olsen | 03:37 pm | February 14, 2022
A study published in JAMA Network Open found CCBT led to improved depressive symptoms in primary care patients compared with treatment as usual alone.
By Emily Olsen | 01:14 pm | February 14, 2022
The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
By Adam Ang | 03:41 am | February 14, 2022
The feature will be introduced in the second quarter of the year.
By Dr. Liz Kwo | 11:44 am | February 11, 2022
Precision genomics could impact the payer, provider and life science space. 
HIMSS22
By Emily Olsen | 10:39 am | February 11, 2022
In a preview of their HIMSS22 session, Serena Bumpus of Ascension and Stephanie Hoelscher of the Texas Tech University Health Sciences Center explain their Texas pilot study on crisis documentation during COVID-19 surges and how it could lessen the burden on nurses.